JavaScript is disabled for your browser. Some features of this site may not work without it.
  • About K
  • Academics
  • Admission
  • Alumni Relations
  • Giving to K
  • News & Events
  • Student Life
  • HORNET HIVE
  • ATHLETICS
  • SITEMAP
  • WEBMAIL
    • Login
    View Item 
    •   CACHE Homepage
    • Academic Departments, Programs, and SIPs
    • Chemistry
    • Chemistry Senior Integrated Projects
    • View Item
    •   CACHE Homepage
    • Academic Departments, Programs, and SIPs
    • Chemistry
    • Chemistry Senior Integrated Projects
    • View Item

    Ultrasensitive Detection of Minimal Residual Disease After Allogeneic HSCT Augmented with pegIFNα in High-Risk AML Patients

    Thumbnail
    View/Open
    Searchable PDF/Kalamazoo College Only (464.6Kb)
    Date
    2019-09-01
    Author
    Amyx-Sherer, Kristen R.
    Metadata
    Show full item record
    Abstract
    Acute Myeloid Leukemia (AML) is one of the most common types of adult leukemia. AML is the result of the failure of myeloid cells in the bone marrow to differentiate into more mature cells. The most successful treatment for patients is chemotherapy and allogenic hematopoietic stem cell transplantation (HSCT). However, HSCT is not always successful and patients with AML who relapse are less likely to survive. At the University of Michigan, 36 patients with AML that did not reach clinical remission enrolled in the pegIFNα clinical trial to test the effectiveness of pegIFNα, polyethylene glycol attached to interferon-α, accompanied with HSCT delaying or preventing relapse. Measurement of minimal residual disease (MRD) or the small number of leukemic cells present, and droplet digital PCR (ddPCR) was used in this study to indicate the likelihood of patient relapse. MRD was measured using ddPCR to see if the trial delayed or prevented relapse in patients. Out of the 36 patients, only 12 survived after four years of observation. Patients observed 56 days post treatment with minimal residual disease (MRD) present were more likely to relapse than compared to those with no MRD (p-value=0.0231). Most data in this observation was not significant due to the small sample size, but there was a noticeable prolongation of survival in patients that were MRD negative after treatment.
    URI
    https://cache.kzoo.edu/handle/10920/38597
    Collections
    • Chemistry Senior Integrated Projects [934]

    Browse

    All of CACHECommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    DSpace software copyright © 2002-2023  DuraSpace
    DSpace Express is a service operated by 
    Atmire NV
    Logo

    Kalamazoo College
    1200 Academy Street
    Kalamazoo Michigan 49006-3295
    USA
    Info 269-337-7000
    Admission 1-800-253-3602

    About K
    Academics
    Admission
    Alumni Relations
    Giving to K
    News & Events
    Student Life
    Sitemap
    Map & Directions
    Contacts
    Directories
    Nondiscrimination Policy
    Consumer Information
    Official disclaimer
    Search this site


    Academic Calendars
    Apply
    Bookstore
    Crisis Response
    Employment
    Library
    Registrar
    DSpace Express is a service operated by 
    Atmire NV